ACELYRIN
ACELYRIN Logo
About ACELYRIN
ACELYRIN Inc. is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for immune-mediated diseases. Its lead product candidate, izokibep, is in Phase 3 clinical trials for Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, and Phase 2 trials for Axial Spondyloarthritis. The company is also developing lonigutamab for thyroid eye disease and SLRN-517 for chronic urticaria. Founded in 2020 and headquartered in Agoura Hills, California, ACELYRIN aims to provide life-changing treatment options for patients.
Address
4149 Liberty Canyon Road,
Agoura Hills, 91301
United States
Year founded
2020
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
